Chang, NJ
Biau-Hung Chang, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20110046338 | Copolyester polyols, prepolymers, and polyurethane elastomers formed therefrom and processes for making same - Polyurethane elastomers formed from prepolymers derived from copolyester polyols. The copolyester polyols have segments derived from one or more polyesters and caprolactone or polycaprolactone. The polyurethane elastomers have good hardness stability at temperatures ranging from 0° C. to 30° C. and preferably have good hydrolytic stability. | 02-24-2011 |
Charles Chang, Wayne, NJ US
Patent application number | Description | Published |
---|---|---|
20080251096 | Cosmetic compact - A dual dispensing mode cosmetic compact for use with a cosmetic powder puff, cosmetic applicator sponge, or cosmetic brush, has a base member with an annular lip, a well to hold a cake of cosmetic material, and a closure lid receivable onto the base member. A scraper member located adjacent the well is engageable with the upper surface of the cosmetic cake. Finger-engageable structures adjacent to the well are turnable thereon, and there is a driving connection between the finger-engageable structures and the scraper member, which effects corresponding turning movement of the latter during turning of the finger-engageable structures. In one mode, the scraper member shaves off limited quantities of the upper surface of the cosmetic cake to produce controlled amounts of dust-like cosmetic powder particulates therefrom. In another mode, the scraper member is shifted by the user, to a second position remote from and outside of the annular lip. This second position fully exposes the upper surface of the cosmetic cake and enables direct access to the cake surface by a cosmetic powder puff, cosmetic applicator sponge, or cosmetic brush. | 10-16-2008 |
20090044826 | Cosmetic compact - A cosmetic compact providing a molded plastic base, a first cover and combined second cover and grip handle, all disposed over the base. The first cover is hinged to the base. The combined second cover and grip handle are selectively removable from the base, and carry an applicator device which when stored, is disposed between the first cover and base. The arrangement enables the user to quickly open the first cover and immediately remove and manipulate the combined second cover and grip handle, and attached applicator device, for application of cosmetic to the face or body. An especially neat, compact construction thereby is realized. | 02-19-2009 |
20100219188 | Aluminum container - An aluminum container for dispensing beverage, includes a can having a cylindrical side wall, and transverse top and bottom walls. A pull tab mechanism is provided on the top wall to effect opening of the container. The transverse top wall has an upstanding peripheral rim, with one or two interrupted wall portions, one of said portions forming a spout for pouring the contents, or drinking from the container directly. The other of the interrupted wall portions provides a clearance space for facilitating the insertion of the user's finger beneath the pull tab in readiness for opening the container. The bottom wall of the container is provided with a removable appliqué, which may contain printed text/pictorial information, or information in the nature of a store or manufacturer's product coupon. | 09-02-2010 |
Chia Ming Chang, Eatontown, NJ US
Patent application number | Description | Published |
---|---|---|
20140070732 | Dielectric laser electron accelerators - A laser-driven dielectric electron accelerator is composed of a dielectric photonic crystal accelerator structure having an electron beam channel and buried grating whose elements are arranged linearly parallel to the electron beam channel. The accelerator structure preferably has a thin film material coating. The grating may have an asymmetric structure. The accelerator and undulator structures may be integrated with on-chip optical and electronic devices such as waveguide devices and control circuits so that multiple devices can be fabricated on the same chip. | 03-13-2014 |
Ching H. Chang, Fanwood, NJ US
Patent application number | Description | Published |
---|---|---|
20110046056 | APOA-1 PEPTIDE MIMETICS - The invention relates to peptide mimetics for treating disorders associated with hypercholesterolemia and cardio-vascular disease. In particular, the invention relates to peptides that mimic the activity of apolipoprotein A-I (Apo AI). | 02-24-2011 |
Chuan-Chuen Chang, Holmdel, NJ US
Patent application number | Description | Published |
---|---|---|
20120320785 | METHOD AND APPARATUS FOR MANAGING PACKET CONGESTION - A method and apparatus for addressing a congestion condition in a communication network are disclosed. For example, the method receives an alert for at least one of: a trunk or a Permanent Virtual Circuit (PVC), where the trunk or the PVC is associated with a route. The method determines whether the alert is associated with a congestion condition by determining whether a trunk utilization has exceeded a first predetermined threshold for the trunk or for the at least one trunk supporting the PVC. The method then rebuilds the route if the first predetermined threshold is exceeded for the trunk or for the at least one trunk supporting said PVC. | 12-20-2012 |
20130301426 | Method and System for Silent Trunk Failure Detection - A system and method for performing a first diagnostic test on a first class of service on a network link during a current measurement period, performing at least one further diagnostic test on a second class of service on the network link during the current measurement period, determining whether an alert was present during a previous measurement period and generating a current failure alert based on results of the first and the at least one further diagnostic tests if an alert was present during the previous measurement period. | 11-14-2013 |
Daphne Chang, Montville, NJ US
Patent application number | Description | Published |
---|---|---|
20110271574 | SYSTEM AND METHOD FOR WEAPON DISCHARGE INHIBITION - A firing inhibition system for a firearm includes an electromechanical actuator electrically connected to a dynamic grip recognition module including at least one sensor and a microcontroller, wherein the at least one sensor is located in a portion of a firearm operable to receive grip pressure from a user and wherein the at least one sensor is operable to transmit a signal to the microcontroller, wherein the microcontroller is operable to receive programming comprising grip pressure of an authorized user and is operable to interpret whether the grip pressure of the user matches the grip pressure of the authorized user, and to send a signal to the electromechanical actuator to actuate or to not actuate. | 11-10-2011 |
Dustin S. Chang, Mt. Laurel, NJ US
Patent application number | Description | Published |
---|---|---|
20110277848 | Acoustical Fluid Control Mechanism - An acoustical fluid control mechanism and a method of controlling fluid flow of a working fluid with the acoustical fluid control mechanism are provided. The mechanism comprises a resonance chamber that defines a cavity. The resonance chamber has a port. The cavity is sealed from the ambient but for the port for enabling oscillatory flow of a working fluid into and out of the cavity upon exposure of the resonance chamber to an acoustic signal containing a tone at a frequency that is substantially similar to a particular resonance frequency of the resonance chamber. The mechanism further includes a rectifier for introducing directional bias to the oscillatory flow of the working fluid through the port. The rectifier has an inlet connected to the port and an outlet for transmitting the directional flow of the working fluid away from the cavity. The outlet is in fluid communication with the port of the resonance chamber at least during transmission of the directional flow of the working fluid therethrough. | 11-17-2011 |
Emily Chang, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20120305174 | LAYER PROCESSING FOR PHARMACEUTICALS - Layer processing for pharmaceuticals, and related systems, methods, and articles are generally described. In some embodiments, ingestible pharmaceutical products (e.g., tablets) can be formed by processing one or more layers containing a pharmaceutically active composition. For example, at least one layer containing a pharmaceutically active composition can be manipulated (e.g., folded, rolled, stacked, etc.) such that the average thickness of the product formed by the manipulation is at least about two times the average thickness of the portions of the layer(s) used to form the product. In some embodiments, after the layer is manipulated, it can be processed (e.g., cut, coated, etc.) to form a final product such as, for example, a tablet. | 12-06-2012 |
Emily P. Chang, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20120135080 | Core-Shell Magnetic Particles and Related Methods - The invention provides core-shell magnetic particles comprising a magnetic core and a functional shell, methods for making same, methods of separation using same, methods for using same, and devices comprising same. The particles and methods of the invention are useful for targeting and removing substances of interest that may be found in complex mixtures. | 05-31-2012 |
Fangzhe Chang, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20100070805 | Method and Apparatus for Validating System Properties Exhibited in Execution Traces - The invention includes a method and apparatus for validating system properties exhibited in execution traces. In one embodiment, a method for testing a system under test (SUT) includes determining a system testing result for the SUT using at least one structured term generated by monitoring an execution trace of the SUT using at least one parameterized pattern. A test procedure is executed for the SUT. The test procedure has at least one parameterized pattern associated therewith. An execution trace generated during execution of the test procedure is parsed, where the execution trace includes unstructured information and the execution trace is parsed using the at least one parameterized pattern to identify at least one matching pattern. A system testing result for the SUT is determined using at least one structured term that is generated using the at least one matching pattern. In this manner, behavior of the system under test during the test procedure may be validated. | 03-18-2010 |
20100180280 | SYSTEM AND METHOD FOR BATCH RESOURCE ALLOCATION - A system for configuring resources in an environment for use by at least one process. In one embodiment, the system includes: (1) a process sorter configured to rank the at least one process based on numbers of resources that steps in the at least one process can use, (2) an optimizer coupled to the process sorter and configured to employ an optimization heuristic to accumulate feasible allocations of resources to the steps based on the ranking of the at least one process, (3) a resource sorter coupled to the optimizer and configured to rank the resources in a non-decreasing order based on numbers of the steps in which the resources can be used, the optimizer further configured to remove one of the resources from consideration based on the ranking of the resources until infeasibility occurs and (4) an environment configuration interface configured to allow the environment to be configured in accordance with remaining ones of the resources. | 07-15-2010 |
20120002884 | METHOD AND APPARATUS FOR MANAGING VIDEO CONTENT - Video files stored in a data store are managed by analyzing the semantic relationship of at least one associated descriptive tag of a given video file to tags associated with video files in the data store. The results of the analysis are used to select a set of video files from those stored in the data store. The content of the given video file is compared with the content of the selected set to determine the similarity of the content. The results of the determination may be used to update information concerning the similarity of video files in the data store, for example, to be used in providing results in response to a search query. | 01-05-2012 |
20120177296 | METHOD AND APPARATUS FOR COMPARING VIDEOS - In a method of comparing a query video and a target video, frames of the query video and frames of the target video arc partitioned into blocks. The mean intensity value is calculated for each block. Minima and maxima values are extracted from temporal changes of the mean intensity values for each block. Inclines and declines are obtained from the minima and maxima values. The inclines and declines are used in determining if alignment exists between the query video and the target video. | 07-12-2012 |
20120189212 | METHOD AND APPARATUS FOR COMPARING VIDEOS - A method for comparing a query video and a target video includes partitioning frames of the query video and frames of the target video into blocks and calculating the mean intensity value for each block. A plurality of query time series is produced for the query video, each query time series representing temporal variation in mean intensity value for blocks from the same location in different frames of the query video. A plurality of target time series is produced for the target video, each target time series representing temporal variation in mean intensity value for blocks from the same location in different frames of the target video the query time series and the target time series are used in determining if alignment exists between the query video and the target video. | 07-26-2012 |
20130039587 | METHOD AND APPARATUS FOR COMPARING VIDEOS - A method for comparing videos includes detecting local features in frames of a video and determining the positions of detected local features in a first frame compared to their respective positions in a succeeding second frame. For at least some of the detected local features, a movement indicator is generated representing the position of a local feature in the first frame relative to the position of that local feature in the second frame, the movement indicator including an orientation, to obtain a plurality of movement indicators. Movement indicators are grouped by orientation ranges. The number of grouped movement indicators in an orientation range are summed to obtain a value for that orientation range. A time series of values for at least one given orientation range is obtained by determining the positions of detected local features in a first frame compared to their respective positions in a succeeding second frame for a plurality of pairs of frames. For at least one orientation range, a first time series of values for a first video is compared with a second time series of values for a second video to determine the similarity of the first and second videos. | 02-14-2013 |
20130191519 | Component Placement for Application-Level Latency Requirements - Methods, systems, and apparatuses for component placement based on application-level latency requirements are provided. Component placement includes receiving a request for a location assignment of an application component or for location assignment of multiple application components within a cloud computing platform. A set of potential location assignments is determined for the application component within the cloud computing platform. A mapping is iteratively determined based on the set of potential location assignments and a latency performance threshold, and a location assignment is selected for the application component based on the mapping. | 07-25-2013 |
Han Chang, Princeton Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20090042226 | Identification and cloning of a full-length human CLNK-related gene, MIST (MAST cell immunoreceptor signal transducer) - The present invention describes a newly discovered full-length polynucleotide encoding an SH2 domain-containing adapter protein, called human MIST, cloned, isolated and identified from a human spleen cDNA library. Also described are the MIST polypeptide sequence, expression vectors, host cells, agonists, antagonists, antisense molecules, and antibodies related to the polynucleotide and/or polypeptide of the present invention. Novel splice variant forms of human MIST are provided. Methods for screening for modulators, particularly inhibitors, of the MIST protein and use of the human MIST polynucleotide and polypeptide for therapeutics and diagnostics are described. | 02-12-2009 |
20090215995 | B-7 related nucleic acids and polypeptides useful for immunomodulation - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 08-27-2009 |
20100125127 | B7-related nucleic acids and polypeptides useful for immunomodulation - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 05-20-2010 |
20100136575 | B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 06-03-2010 |
20110294162 | B-7 RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 12-01-2011 |
20120329990 | B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 12-27-2012 |
20130144042 | B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 06-06-2013 |
20140154260 | B-7 RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 06-05-2014 |
20140194598 | B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION - The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject. | 07-10-2014 |
20140309229 | METHODS FOR SELECTING AND TREATING CANCER IN PATIENTS WITH IGF-1R/IR INHIBITORS - The present invention relates generally to the field of pharmacogenomics, and more specifically to methods and procedures to determine drug sensitivity in patients to allow the identification of individualized genetic profiles which will aid in selecting cancer patients that are responsive to IGF-1R/IR inhibition. | 10-16-2014 |
Huiwen Chang, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20150131924 | Creation of Rectangular Images from Input Images - Stitched images generated from combinations of multiple separate images mostly have irregular boundaries. Users generally prefer rectangular boundaries. Techniques for warping an image with irregular boundaries to give the image rectangular boundaries are disclosed herein. Preliminary warping of the image into the rectangle provides a rectangular shape on which to overlay a mesh. The image is reverted to its original shape with irregular boundaries and the mesh is warped accordingly. Global optimization is applied to the image by finding an energy minimum, or reduced energy below a threshold, for a function that gives the image a rectangular shape while preserving shapes and preserving straight lines. The mesh is warped according to the solution of the function and the image is stretched and/or compressed along with the mesh. This approach generates results that are qualitatively more visually attractive than other contemporary techniques. | 05-14-2015 |
Hyunseok Chang, Holmdel, NJ US
Patent application number | Description | Published |
---|---|---|
20110202646 | POLICY CONTROLLED TRAFFIC OFFLOAD VIA CONTENT SMART-LOADING - An example method includes receiving at a user device a policy from a communication network node, and loading the user device with content data based on the policy. The policy specifies a rule set and a corresponding action to undertake in the event of a condition satisfying the rule set and may be received at the user device in response to connection of the user device to the network node. The policy received may be an updated policy, and may be based on network conditions. Example apparatuses and methods determine how (for example, what access technology and what times, to best deliver content given the particulars for a user and the device state of the user, using a rules set that can be dynamically updated without user intervention by network operators based on network management policies. Delivery includes upload, download and sideload of a user device. | 08-18-2011 |
20120284727 | Scheduling in Mapreduce-Like Systems for Fast Completion Time - A method and system for scheduling tasks is provided. A plurality of lower bound completion times is determined, using one or more computer processors and memory, for each of a plurality of jobs, each of the plurality of jobs including a respective subset plurality of tasks. A task schedule is determined for each of the plurality of processors based on the lower bound completion times. | 11-08-2012 |
20130254248 | Method And Apparatus For A Distributed File System In A Cloud Network - Various embodiments provide a method and apparatus of providing a distributed network file system in a cloud network that provides performance guarantees in cloud storage that are independent of the accessed files and the access locations. A client's file system is provisioned using a file placement strategy that is based on client's access locations and determined maximum access bandwidths and does not require knowledge of file access patterns. | 09-26-2013 |
20140315570 | LOCALIZATION SYSTEMS AND METHODS - A system and method for providing localization of a mobile electronic device within an environment includes at least one server in communication with the mobile electronic device. The at least one server is adapted to receive at least one picture and at least one accelerometer measurement from the mobile electronic device. The at least one server includes a localization module that provides localization to the mobile electronic device based on the at least one picture, the at least one accelerometer measurement and on at least one 3-dimensional map of the environment. | 10-23-2014 |
20150341647 | ACCELERATED IMAGE PROCESSING - An illustrative example method of processing image data includes dividing a block of data into a plurality of sub-blocks, the block of data corresponding to at least one image; selecting at least one of the sub-blocks according to a predetermined sequence; identifying a plurality of features of interest in the selected sub-block; and processing the selected sub-block to provide information regarding at least one of the features of interest. | 11-26-2015 |
20160094668 | METHOD AND APPARATUS FOR DISTRIBUTED CUSTOMIZED DATA PLANE PROCESSING IN A DATA CENTER - Systems and methods for providing data plane services in a data center include receiving a request for a data plane service from a tenant of a host in the data center. In response to receiving the request, a service process is instantiated at the host for performing the data plane service for a virtual machine of the tenant. | 03-31-2016 |
James W. Chang, Mendham, NJ US
Patent application number | Description | Published |
---|---|---|
20140105955 | THERMOPLASTIC FLUOROPOLYMER-COATED MEDICAL DEVICES - A medical device provided with at least a partial surface coating of a thermoplastic copolymer of tetrafluoroethylene and perfluoroalkylvinylether that is free of cross-linking monomers and curing agents. The fluoropolymer coating is preferably an amorphous thermoplastic, is highly inert and biocompatible, has elastomeric characteristics that provide desirable mechanical properties such as good flexibility and durability. These characteristics allow the coating to be considered “functionally transparent” because it withstands mechanical deformations required for the assembly, deployment, expansion, and placement of medical devices, without any adverse effect on the mechanical and biological functionality of the coated device. Further, its inertness, derived from the perfluorocarbon structure, contributes to its functionally transparent nature. The coating can be provided with various liquid or solid additives, can be loaded with large quantities of additives including a wide range of therapeutic agents, and has excellent drug elution characteristics when elutable additives are used. | 04-17-2014 |
Jeanne Chang, Madison, NJ US
Patent application number | Description | Published |
---|---|---|
20090186794 | DETERGENT COMPOSITION COMPRISING A BLOCK COPOLYMER - The invention relates to a detergent composition, suitable for use in dish washing or laundry, comprising at least 15% of a detersive surfactant(s), and a block copolymer, selected from the group consisting of (block A)-(block B) diblock copolymers, (block A)-(block B)-(block A) triblock copolymers, and (block B)-(block A)-(block B) triblock copolymers, wherein block A and block B derive from alpha ethylenically unsaturated monomers, at least one block being water-soluble. The detergent compositions provide an increased cleaning, and/or a decreased redeposition of the fatty substances once they are removed from a substrate. | 07-23-2009 |
John Chang, Parsippany, NJ US
Patent application number | Description | Published |
---|---|---|
20130262162 | SYSTEM AND METHOD FOR PROVIDING IMMEDIATE CONFIRMATION FOR SHIPPING SERVICES - A method and related system allow reservations of shipping slots on a vessel. The method includes accepting for pre-allocation from a carrier, slots on a voyage of the vessel, corresponding carrier booking numbers for the slots, and shipping rules for the slots. A booking request from a shipper is accepted to reserve one or more of the pre-allocated slots on the vessel, together with shipping information for the booking request. The shipping information is correlated against the shipping rules for the slots to determine if the booking request can be accepted. If the booking request can be accepted, the carrier booking numbers corresponding to the reserved slots are then provided to the shipper, and the corresponding slots are marked as reserved. | 10-03-2013 |
Kenneth Chang, West Windsor, NJ US
Patent application number | Description | Published |
---|---|---|
20130218767 | Web Enabled Bank Teller Machine - A system and method is provided for an ATM having a display, a logic server coupled to the display, and a memory coupled to the logic server. The logic server dynamically controls the content of screens to be displayed on the display. The memory, which is accessible to the logic server, contains a profile of at least one user. | 08-22-2013 |
Kirk Chang, Morganville, NJ US
Patent application number | Description | Published |
---|---|---|
20100011118 | Call admission control and preemption control over a secure tactical network - In a secure network where the network characteristics are not known, a call admission control algorithm and a preemption control algorithm based on a destination node informing the source node of the observed carried traffic are used to regulate the amount of traffic that needs to be preempted by the source. The amount of traffic that needs to be preempted is based on the carried traffic measured at the destination node. The traffic to be preempted is based on the priority of the traffic, where the lowest priority traffic is the first to be preempted until the amount of traffic preempted is sufficient to allow the remaining traffic to pass through the network without congestion. | 01-14-2010 |
20110211480 | Call Admission Control and Preemption Control Over a Secure Tactical Network - In a secure network where the network characteristics are not known, a call admission control algorithm and a preemption control algorithm based on a destination node informing the source node of the observed carried traffic are used to regulate the amount of traffic that needs to be preempted by the source. The amount of traffic that needs to be preempted is based on the carried traffic measured at the destination node. The traffic to be preempted is based on the priority of the traffic, where the lowest priority traffic is the first to be preempted until the amount of traffic preempted is sufficient to allow the remaining traffic to pass through the network without congestion. | 09-01-2011 |
Kirk K. Chang, Morganville, NJ US
Patent application number | Description | Published |
---|---|---|
20100220629 | Estimating Available Bandwidth And Enhancing Narrow Link Bandwidth Estimations In Telecommunications Networks Using Existing User Traffic - Without using additional probing packets, estimates of the narrow link bandwidth and available bandwidth of a network path are computed based on existing traffic. The network can be of different types such as a wireless battlefield network context or a wired or wireless commercial network environment. “Fast packets”, i.e. those packets which do not experience any queuing delay in the network, are identified. Fast packets are identified to resolve end-to-end packet delay into its constituent components (deterministic, transmission and queuing delays), estimate path utilization and eliminate the uncertainty (false alarms) that causes the prior art method to lose its effectiveness. An estimation algorithm computes end-to-end transmission delay and end-to-end deterministic delay of fast packets traveling along a path in a network. Examples of deterministic delay include satellite propagation delays and clock effects. Then, based on the results of the fast packet identifying algorithm, two logic branches are followed. A first branch calculates utilization and a second branch calculates narrow link bandwidth. The narrow link bandwidth is determined from the packet pair dispersion. The available bandwidth is obtained from the narrow link bandwidth and the utilization. Estimation of available bandwidth for an end-to-end network path allows traffic sources to judiciously regulate the volume of application traffic injected into the network. | 09-02-2010 |
Lehua Chang, Rahway, NJ US
Patent application number | Description | Published |
---|---|---|
20110028481 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 02-03-2011 |
Lehua Chang, Ramsey, NJ US
Patent application number | Description | Published |
---|---|---|
20090253705 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 10-08-2009 |
20110028461 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 02-03-2011 |
20120157432 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 06-21-2012 |
20120225886 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 09-06-2012 |
20120258963 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor. | 10-11-2012 |
20130225599 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS - The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of b3-adrenoceptor. Formula (I). | 08-29-2013 |
20140057893 | SUBSTITUTED CYCLOPROPLY COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT - Substituted cyclopropyl compounds of the formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included | 02-27-2014 |
Leo Yih Lang Chang, Livingston, NJ US
Patent application number | Description | Published |
---|---|---|
20120222215 | PORTABLE LIGHTWEIGHT BED - A lightweight bed assembly kit includes slats and runners adapted for connection to each other at spaced apart locations to form a grid. A U-shaped channel member is adapted for connection to the grid to form a support frame. A covering constructed to form a substantially smooth sleeping surface for an adult human is sized and shaped to be disposed on a top surface of the support frame. A method of assembling a lightweight bed includes arranging runners and slats transversely to each other and connecting the runners and slats together to form a grid. A U-shaped channel member is connected to the grid to form a support frame. A covering constructed to form a substantially smooth sleeping surface is mounted on a top surface of the support frame. A second support frame can be connected to the first support frame by another U-shaped channel member. | 09-06-2012 |
20130312800 | PORTABLE SHELTER - A portable shelter is erectable on a support surface for providing short to long term housing for humans. In general, the shelter includes a foundation, a floor supported by the foundation, and an enclosure. The shelter defines an interior which may be inhabited by a human. The shelter may include front, rear, side, and top walls, all of which may be folded to define inboard and outboard folds which enhance the structural integrity of the walls. The floor of the structure may include indentations corresponding to inboard folds of one or more walls for receiving the inboard folds for enhancing structural integrity of the shelter. The floor may be folded to form upstanding portions adjacent the indentations for securing the inboard folds in the indentations. Moreover, the walls may be folded to define feet which engage the support surface. | 11-28-2013 |
20150344190 | PLASTIC LINER BAG WITH DRAWSTRING - A plastic can liner and a drawstring for closing the can liner. First and second plastic panels joined along edges of the panels define a bag body. Opposed first and second panel edges that are not joined define a can liner opening. A first hem extends along the first panel edge and a second hem extends along the second panel edge. A drawstring extends through the first and second hems. The drawstring is a cross-laminated plastic film. In some embodiments, the drawstring includes first and second drawstring strips sealed together adjacent the opposite ends thereof. Each of the first and second drawstring strips can be made from a plastic film including a first layer and a second layer bonded to the first layer. Each of the first and second layers have a machine direction oriented transverse to the length of the drawstring and the machine direction of the other layer. | 12-03-2015 |
Linda Chang, Wayne, NJ US
Patent application number | Description | Published |
---|---|---|
20100152185 | DIPHENYL SUBSTITUTED CYCLOALKANES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE - The instant invention provides compounds of formula I which are 5-lipoxygenase activating protein inhibitors. | 06-17-2010 |
Linda L. Chang, Wayne, NJ US
Patent application number | Description | Published |
---|---|---|
20090197883 | Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use - The instant invention provides compounds of Formula (I) which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. | 08-06-2009 |
20090258884 | Substituted amides - Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver. | 10-15-2009 |
20090258885 | Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis - The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. | 10-15-2009 |
20100317645 | SUBSTITUTED DIAZEPINE SULFONAMIDES AS BOMBESIN RECEPTOR SUBTYPE-1 MODULATORS - Certain novel substituted diazepine sulfonamides are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes. | 12-16-2010 |
20110144056 | PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH - The present invention is directed to certain imidazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer disease, and Parkinson's disease | 06-16-2011 |
Luis Chang, Englewood, NJ US
Patent application number | Description | Published |
---|---|---|
20120221460 | METHOD AND SYSTEM FOR FACILITATING SECURED COMMERCIAL TRANSACTIONS THROUGH TRUSTED AGENTS - The present invention discloses a member-based trade management system for facilitating trade among consumers and producers by utilizing an agent service. The system comprises a network-based communications module for storing and providing profile information about consumers, producers, and third-party service providers; a member matching service module for presenting candidates for a transaction group; a member research service module for examining credentials of candidates for the transaction group; a transaction service module for tracking a transaction workflow; a financial service module for ensuring exchange of financial values between consumers and producers; a platform management service module for mediating disputes arising from activities related to the trade transaction; and one transaction service facilitation unit for allowing consumer and producer agents to access data in the trade platform, wherein the customer and producer agents, located in close proximity of the customers and producers, to facilitate the completion of the trade transaction. | 08-30-2012 |
Mun Kyung Chang, Westampton, NJ US
Patent application number | Description | Published |
---|---|---|
20110061669 | Hand Rest Vacuum and Method - A hand rest vacuum and method is provided for the nail care industry. A body is configured to be supported by a desk between a client and a nail care technician. A cushioned hand rest pad is supported by the body. The body has a retractable nozzle on the technician side of the body. The nozzle is in fluid communication through an interior volume of the body to a body discharge location. Air is pulled through the nozzle opening and through the body interior volume by a vacuum source. The vacuum source may be located within the body interior volume or may be located separately from the body. The interior volume may incorporate a particulate filter, a carbon filter or a cyclone particulate matter separator. | 03-17-2011 |
Nicholas Chang, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20160036556 | SIGNAL JAMMING SUPPRESSION - Provided are processes for suppressing jamming signals that may include use of a signal processing circuit. A signal processing circuit can be configured to obtain a jamming signal and a feedback signal, process the jamming signal and the feedback signal to determine a cancellation signal for use in suppressing the jamming signal, and output the cancellation signal to a radio-frequency transmitter. The signal processing circuit may be further configured to obtain a transmission signal, determine a jamming channel from the jamming signal and a feedback channel from the feedback signal, and combine the transmission channel, jamming channel, and feedback channel to determine a transfer function, where the transfer function is configured to determine the cancellation signal. | 02-04-2016 |
Richard L. Chang, Pinebrook, NJ US
Patent application number | Description | Published |
---|---|---|
20140017194 | Compositions And Methods Of Use Of Phorbol Esters - Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of cytopathic diseases. Cytopathic diseases may be caused by a variety means such as viral infections like HIV and AIDS, or the development of neoplasms in a mammalian subject. The methods and compositions of the invention are effective for inhibiting de novo HIV infection, upregulating viral expression from latent provirus, inhibiting HIV-induced cytopathic effects, down regulating the HIV receptor, increasing Th1 cytokine expression, decreasing Th2 cytokine expression, increasing ERK phosphorylation, inducing apoptosis in malignant cells, inducing remission, maintaining remission, as chemotherapeutic agents, as well as for decreasing symptoms of cytopathic diseases and opportunistic infections that may accompany such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent such as those used in HAART protocols, therapeutic agents used to treat opportunistic infections due to HIV, or chemotherapeutic agents to yield more effective treatment tools against cytopathic diseases in mammalian subjects. | 01-16-2014 |
Richard Yen-Hsiang Chang, Bloomfield, NJ US
Patent application number | Description | Published |
---|---|---|
20090041170 | Dynamic phase alignment methods and apparatus - Dynamic phase alignment circuitry selects from among several, phase-distributed, candidate clock signals the one of those signals that is currently best for use in controlling the timing of sampling of a serial data signal to recover the data from that signal. The circuitry selects two phase-adjacent ones of the candidate clock signals that are currently the two best candidates for final selection. The circuitry makes a final selection of the generally better one of these two best candidates in a way that avoids unproductive switching back and forth between these two best candidates. | 02-12-2009 |
Robert Chang, Cherry Hill, NJ US
Patent application number | Description | Published |
---|---|---|
20110136162 | Compositions and Methods for Functionalized Patterning of Tissue Engineering Substrates Including Bioprinting Cell-Laden Constructs for Multicompartment Tissue Chambers - The present invention relates to microfluidic systems and methods for monitoring or detecting a change in a characteristic of an input substance. Specifically, the invention relates to a model for in vitro pharmacokinetic study and other pharmaceutical applications, as well as other uses including computing, sensing, filtration, detoxification, production of chemicals and biomolecules, testing cell/tissue behavior, toxicology, drug metabolism, drug screening, drug discovery, and implantation into a subject. The present invention also relates to systems and methods of a microplasm functionalized surface patterning of a substrate. The present invention represents an improvement over existing plasma systems used to modify the surface of a substrate, as the present invention creates surface patterning without the use of a mask, stamp or a chemical treatment. | 06-09-2011 |
20110177590 | Bioprinted Nanoparticles and Methods of Use - The present invention provides compositions and methods that combine the initial patterning capabilities of a direct cell printing system with the active patterning capabilities of magnetically labeled cells, such as cells labeled with superparamagnetic nanoparticles. The present invention allows for the biofabrication of a complex three-dimensional tissue scaffold comprising bioactive factors and magnetically labeled cells, which can be further manipulated after initial patterning, as well as monitored over time, and repositioned as desired, within the tissue engineering construct. | 07-21-2011 |
Robert Chang, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20100005103 | DISTRIBUTED APPLICATION MANAGEMENT SOFTWARE - A system and method is provided for remote administration and management of a computer network, by installation of distributed software agents in remote network components, such as software agents implemented using encapsulated reusable interfaces such as COM or CORBA interfaces. Remote network management is effected by communication with the distributed agents using a structured language-independent parsable text document, such as a markup language; e.g. XML. | 01-07-2010 |
Robert C. Chang, Cherry Hill, NJ US
Patent application number | Description | Published |
---|---|---|
20090263849 | Bioprinting Three-Dimensional Structure Onto Microscale Tissue Analog Devices for Pharmacokinetic Study and Other Uses - A microfluidic system for monitoring or detecting a change in a parameter of an input substance, which includes a microfluidic device having a tissue chamber and a tissue analog placed in the tissue chamber, wherein the tissue analog has a vessel structure mimicking naturally occurring vessel network incorporated in the tissue analog. | 10-22-2009 |
Shean-Guang Chang, Morris Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20090259715 | SYSTEM AND METHOD FOR CLIENT INTEROPERABILITY - Disclosed herein is a system and method for client interoperability. In one embodiment, a method for client interoperability comprises establishing a network connection between a client and a proxy. The client requests a connection factory from the proxy. The proxy then obtains the connection factory from an application server using a Java Naming and Directory Interface (JNDI). Using the connection factory, a connection to a connection host from the client is created. When the client sends a message, the proxy receives the message and routes the message to a destination server. Similarly, when the client receives a message, the proxy receives the message from a destination server and passes the message to the client. The client can be specifically configured to extend JMS operability to a desired language. In one embodiment the client is a .NET client. | 10-15-2009 |
Shen Y. Chang, Rockaway, NJ US
Patent application number | Description | Published |
---|---|---|
20080243587 | Increasing Incremental Spend By A Consumer - A rewards program has been developed that increases incremental spend by a consumer while maximizing the profits to a transactional account company. In an embodiment, a predicted spend of a given consumer over a given time period is calculated. A spend threshold for the consumer is set based on the predicted spend over the given time period. An incremental spend reward offer is then customized for the consumer, where the offer maximizes profits resulting from the offer based on a calculation of consumer profits derived from campaign group responses. The customization may involve, for example, simulating a response of the given consumer to an offer having various combinations of incentive variables, with the customized offer including the combination of incentive variables that maximizes profits resulting from the offer in the simulation. The consumer is rewarded for spend above the spend threshold during the given time period. | 10-02-2008 |
20090254413 | Portfolio Modeling and Campaign Optimization - In an embodiment of the invention, historical data related to multiple members of a customer loyalty program is gathered. A set of loyalty behavior models is developed for an individual member of the loyalty program is developed based on the historical data. For each campaign in a plurality of marketing campaigns, at least one combination of offers is inserted into each loyalty behavior model to output a plurality of net profit scores for the individual member, wherein each combination of offers outputs a separate net profit score. For each campaign in the plurality of campaigns, a combination of offers having the highest net profit score for the campaign is selected. The campaign having the highest net profit score of the plurality of campaigns is selected, and marketing materials for the selected campaign and combination of offers is transmitted to the individual member. | 10-08-2009 |
20150371252 | PORTFOLIO MODELING AND CAMPAIGN OPTIMIZATION - In an embodiment of the invention, historical data related to multiple members of a customer loyalty program is gathered. A set of loyalty behavior models is developed for an individual member of the loyalty program is developed based on the historical data. For each campaign in a plurality of marketing campaigns, at least one combination of offers is inserted into each loyalty behavior model to output a plurality of net profit scores for the individual member, wherein each combination of offers outputs a separate net profit score. For each campaign in the plurality of campaigns, a combination of offers having the highest net profit score for the campaign is selected. The campaign having the highest net profit score of the plurality of campaigns is selected, and marketing materials for the selected campaign and combination of offers is transmitted to the individual member. | 12-24-2015 |
Shih-Ying Chang, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20130164345 | Co-Processing Method and Formulations for HIV Attachment Inhibitor Prodrug Compound and Excipients - A process for the production of a formulation of HIV attachment inhibitor piperazine tris salt prodrug compound involves dissolving the prodrug compound in a solvent to form a solution; adding a first quantity of a first anti-solvent to the solution; then dispersing a first quantity of HPMC in the solution; adding a second quantity of the first anti-solvent to the solution; dispersing a second quantity of HPMC in the solution; then adding a second anti-solvent to the solution so as to crystallize the compound with the HPMC and thereby form the formulation, wherein the second anti-solvent is a combination of acetone and isopropyl acetate (IPAC). The formulation is then washed, and dried. | 06-27-2013 |
20150050335 | Extended Release Pharmaceutical Formulations of Water-Soluble Active Pharmaceutical Ingredients and Methods for Making the Same - The present disclosure relates to methods for making extended-release formulations of water-soluble active pharmaceutical ingredients such as metformin HCl. In one aspect, the disclosure provides a method that includes adding an aqueous solution of an active pharmaceutical ingredient to an agitated mixture of one or more release-modifying polymers and optionally one or more binders in one or more organic solvents, the one or more organic solvents together being an antisolvent for the active pharmaceutical ingredient, water being sufficiently soluble in the one or more organic solvents such that the water added as part of the aqueous solution dissolves in the mixture, the addition thereby precipitating the active pharmaceutical ingredient; separating the active pharmaceutical ingredient and the one or more release-modifying polymers and, if present, the one or more binders from the one or more organic solvents to yield co-processed particles; and drying the co-processed particles. The methods can be used to make dosage forms such as tablets having reduced amounts of release-modifying polymers. | 02-19-2015 |
20160102093 | CO-PROCESSING METHOD AND FORMULATION FOR HIV ATTACHMENT INHIBITOR PRODRUG COMPOUND AND EXCIPIENTS - A process for the production of a formulation of HIV attachment inhibitor piperazine tris salt prodrug compound involves dissolving the prodrug compound in a solvent to form a solution; adding a first quantity of a first anti-solvent to the solution; then dispersing a first quantity of HPMC in the solution; adding a second quantity of the first anti-solvent to the solution; dispersing a second quantity of HPMC in the solution; then adding a second anti-solvent to the solution so as to crystallize the compound with the HPMC and thereby form the formulation, wherein the second anti-solvent is a combination of acetone and isopropyl acetate (IPAC). The formulation is then washed, and dried. | 04-14-2016 |
Shing Yue Chang, Parsippany, NJ US
Patent application number | Description | Published |
---|---|---|
20100040679 | Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage - Compositions useful for treating an individual with nicotine dependence comprising a combination of an α | 02-18-2010 |
Ti-Chiun Chang, Princeton Juction, NJ US
Patent application number | Description | Published |
---|---|---|
20090080756 | Method and system for correcting butting artifacts in X-ray images - A method and system for correcting butting artifacts in x-ray images is disclosed. In order to correct a butting artifact in an x-ray image, a butting artifact region in the x-ray image is normalized. Multiple intensity shift estimators are calculated for each pixel of each line of the butting artifact. Confidence intervals are calculated for each intensity shift estimator. A multiple hypothesis hidden Markov model (MH-HMM) is formulated based on the intensity shift operators and confidence measures subject to a smoothness constraint, and the MH-HMM is solved to determine intensity shift values for each pixel. A corrected image is generated by adjusting the intensity of each pixel of the butting artifact based on the intensity shift value for that pixel. | 03-26-2009 |
Ti-Chiun Chang, Princeton Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20090116713 | Method and system for human vision model guided medical image quality assessment - A method and system for image quality assessment is disclosed. The image quality assessment method is a no-reference method for objectively assessing the quality of medical images. This method is guided by the human vision model in order to accurately reflect human perception. A region of interest (ROI) of medical image is divided into non-overlapping blocks of equal size. Each of the blocks is categorized as a smooth block, a texture block, or an edge block. A perceptual sharpness measure, which is weighted by local contrast, is calculated for each of the edge blocks. A perceptual noise level measure, which is weighted by background luminance, is calculated for each of the smooth blocks. A sharpness quality index is determined based on the perceptual sharpness measures of all of the edge blocks, and a noise level quality index is determined based on the perceptual noise level measures of all of the smooth blocks. An overall image quality index can be determined by using task specific machine learning of samples of annotated images. The image quality assessment method can be used in applications, such as video/image compression and storage in healthcare and homeland security, and band-width limited wireless communication. | 05-07-2009 |
20100092061 | SYSTEM AND METHOD FOR DECOMPOSED TEMPORAL FILTERING FOR X-RAY GUIDED INTERVENTION APPLICATION - A method for temporally filtering medical images during a fluoroscopy guided intervention procedure includes providing a mask image, a fluoroscopy intervention image acquired at a current time during a medical intervention procedure, forming a subtraction image by subtracting the mask image from the intervention image, calculating a motion image of a moving structure in the subtraction image, forming a residual image by subtracting the motion image from the subtraction image, temporally filtering the residual image with a filtered image from a previous time, and adding the motion image to the temporally filtered residual image. | 04-15-2010 |
20100142789 | METHOD FOR CORRECTING MOTION ARTIFACTS IN MAGNETIC RESONANCE IMAGES - For resonance image data of an imaged subject, a method that first detects and estimates the dominant motions of k-space data (i.e., the motion vectors) and then constructs a graphical model for each estimated motion vector. The segments of the k-space that are determined to be corrupted by motion are restored by minimizing the energy associated with the corresponding graphical model. Consequently, the MR image of the imaged subject becomes free of motion artifacts. | 06-10-2010 |
20110064285 | SYSTEM AND METHOD FOR MULTI-IMAGE BASED STENT VISIBILITY ENHANCEMENT - A method for enhancing stent visibility in digital medical images includes providing a time series of 2-dimensional (2D) images of a stent in a vessel, estimating motion of the stent in a subset of images of the time series of images, estimating motion of clutter in the subset of images, where clutter comprises anatomical structures other than the stent, estimating a clutter layer in the subset of images from the estimated clutter motion, estimating a stent layer in the subset of images from the clutter layer and the estimated clutter motion, and minimizing a functional of the estimated stent motion, the estimated stent layer, the estimated clutter motion, and the estimated clutter layer to in calculate a refined stent layer image, where the refined stent layer image has enhanced visibility of the stent. | 03-17-2011 |
20110103674 | MARKER DETECTION IN X-RAY IMAGES - A method for detecting markers within X-ray images includes applying directional filters to a sequence of X-ray image frames. Marker candidate pixels are determined based on the output of the directional filters. Candidate pixels are grouped into clusters and distances between each possible pair of clusters is determined and the most frequently occurring distance is considered an estimated distance between markers. A first marker is detected at the cluster that most closely resembles a marker based on certain criteria and a second marker is then detected at a cluster that is the estimated distance from the first marker. The pair of first and second marker detections is scored to determine detection quality. If the detected marker pair has an acceptable score then the detected marker pair is used. | 05-05-2011 |
20120148129 | Prior Enhanced Compressed Sensing (PRINCE-CS) Reconstruction for Dynamic 2D-Radial Cardiac MRI - A reconstructed image is rendered from a set of MRI data by first estimating an image with an area which does not contain artifacts or has an artifact with a relative small magnitude. Corresponding data elements in the estimated image and a trial image are processed, for instance by multiplication, to generate an intermediate data set. The intermediate data set is transformed and minimized iteratively to generate a reconstructed image that is free or substantially free of artifacts. In one embodiment a Karhunen-Loeve Transform (KLT) is used. A sparsifying transformation may be applied to generate the reconstructed image. The sparsifying transformation may be also not be applied. | 06-14-2012 |
20130121550 | Non-Contrast-Enhanced 4D MRA Using Compressed Sensing Reconstruction - A reconstructed image is rendered of a patient by a processor from a set of undersampled MRI data by first subtracting two repetitions of the acquired data in k-space to create a third dataset. The processor reconstructs the image by minimizing an objective function under a constraint related to the third dataset, wherein the objective function includes applying a Karhunen-Loeve Transform (KLT) to a temporal dimension of data. The objective function under the constraint is expressed as arg min | 05-16-2013 |
20130121554 | IMAGE RECONSTRUCTION USING REDUNDANT HAAR WAVELETS - A method for image reconstruction includes receiving under-sampled k-space data, determining a data fidelity term of a first image of the under-sampled k-space data in view of a second image of the under-sampled k-space data, wherein a time component separated the first image and the second image, determining a spatial penalization on redundant Haar wavelet coefficients of the first image in view of the second image, and optimizing the first image according the data fidelity term and the spatial penalization, wherein the spatial penalization selectively penalizes temporal coefficients and an optimized image of the first image is output. | 05-16-2013 |
20130289912 | EIGEN-VECTOR APPROACH FOR COIL SENSITIVITY MAPS ESTIMATION - A method for estimating a coil sensitivity map for a magnetic resonance (MR) image includes providing ( | 10-31-2013 |
20130320974 | EFFICIENT REDUNDANT HAAR MINIMIZATION FOR PARALLEL MRI RECONSTRUCTION - A method for parallel magnetic resonance imaging (MRI) reconstruction of digital images includes providing a set of acquired k-space MR image data v, a redundant Haar wavelet matrix W satisfying W | 12-05-2013 |
20140036060 | METHODS FOR DEBLENDING OF SEISMIC SHOT GATHERS - A system and methods to deblend seismic data from a plurality of sources and received by a plurality of sensors as shot gathers are disclosed. The deblending is performed by a Mutual Interdependence Analysis Method to separate contributions of different shots. Deblending is also performed by applying a measure of coherence in parallel data domains such as Common Shot Gather and Common Midpoint. Deblending is also achieved by using the hyperbolic nature of seismic data in the common midpoint domain. Deblended signals are estimated and are applied to create a seismic image. Also, Bergman iteration based migration is applied directly on the blended seismic shot gathers without first deblending as an alternative method. The methods are applied in seismic imaging for exploration of natural resources. | 02-06-2014 |
20140088899 | EIGEN-VECTOR APPROACH FOR COIL SENSITIVITY MAPS ESTIMATION - A method for estimating a coil sensitivity map for a magnetic resonance (MR) image includes providing a matrix A of sliding blocks of a 3D image of coil calibration data, calculating a left singular matrix V | 03-27-2014 |
Timothy M. Chang, Montville, NJ US
Patent application number | Description | Published |
---|---|---|
20100210942 | SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS OF BIOLOGICAL STRUCTURES - Ultrasound systems and methods for detecting features of biological tissue, including fracture detection in bone tumor detection are described. Systems and methods may employ low transient pulse technology. Methods employ detection and analysis of behavioral patterns of different signal parameters such as flight time, maximum amplitude, phase angle, and correlation as indicators of the depth of a fracture and may be used in quantitative ultrasound bone fracture detection. Flight time and frequency components may be employed in tumor detection methods. | 08-19-2010 |
20130204132 | SYSTEM AND METHOD FOR ULTRASOUND ANALYSIS OF BIOLOGICAL STRUCTURES - Ultrasound systems and methods for detecting features of biological soft tissue are described. Systems and methods may employ low transient pulse technology. Methods employ detection and analysis of behavioral patterns of different signal parameters such as flight time, maximum amplitude, phase angle, and correlation for tumor detection and tissue analysis. Flight time and frequency components may be employed in tumor detection methods. | 08-08-2013 |
Timothy N. Chang, Montville, NJ US
Patent application number | Description | Published |
---|---|---|
20090253216 | Delivery and Sensing of Metered Amounts of Liquid Materials - A liquid delivery apparatus is provided for depositing liquid materials onto prescribed areas. The apparatus includes a sensing and delivery pin and a photo sensor. The apparatus is sized to deliver a droplet of liquid material to the surface of a target area without coming into contact with the target surface. The apparatus is also capable of drawing geometric features, such as lines and grids of liquid material. The photo sensor measures the intensity of light during a processing cycle. Measured reflected-light intensity can be compared in real-time to a reference curve which is based on test process cycles representing the light intensity expected when the process proceeds in the preferred fashion to produce a normal spot having an expected droplet size. The light intensity measurements can also be fitted with a mathematical function such as an asymmetric double sigmoidal curve. | 10-08-2009 |
20110271574 | SYSTEM AND METHOD FOR WEAPON DISCHARGE INHIBITION - A firing inhibition system for a firearm includes an electromechanical actuator electrically connected to a dynamic grip recognition module including at least one sensor and a microcontroller, wherein the at least one sensor is located in a portion of a firearm operable to receive grip pressure from a user and wherein the at least one sensor is operable to transmit a signal to the microcontroller, wherein the microcontroller is operable to receive programming comprising grip pressure of an authorized user and is operable to interpret whether the grip pressure of the user matches the grip pressure of the authorized user, and to send a signal to the electromechanical actuator to actuate or to not actuate. | 11-10-2011 |
William R. Chang, Colonia, NJ US
Patent application number | Description | Published |
---|---|---|
20090088710 | VOLUME LIMITING BODILY FLUID DRAINAGE SYSTEM - A system and method are disclosed for automatically limiting the drainage of a bodily fluid such as cerebrospinal fluid (CSF) from a patient into a collection chamber. The collection chamber includes a vent having an hydrophobic filter for the passage of air to facilitate the movement of CSF yet to maintain a closed system. The system includes a buoyant float hingedly connected with the top of the collection chamber in one embodiment. When fluid rises in the collection chamber to a predetermined volume, buoyant force raises the float and causes a seal plug mounted on top of the float to seal one of an inflow port or a vent port. The float is limited to pivoting movement in one plane and to a certain angle within that plane. The system and method avoid overdrainage of CSF from the patient and overfilling of the collection chamber. | 04-02-2009 |
20120283676 | METHOD OF CONTROLLING THE FLOW OF BODILY FLUID - A system and method are disclosed for automatically limiting the drainage of a bodily fluid such as cerebrospinal fluid (CSF) from a patient into a collection chamber. The collection chamber includes a vent having an hydrophobic filter for the passage of air to facilitate the movement of CSF yet to maintain a closed system. The system includes a buoyant float hingedly connected with the top of the collection chamber in one embodiment. When fluid rises in the collection chamber to a predetermined volume, buoyant force raises the float and causes a seal plug mounted on top of the float to seal one of an inflow port or a vent port. The float is limited to pivoting movement in one plane and to a certain angle within that plane. The system and method avoid overdrainage of CSF from the patient and overfilling of the collection chamber. | 11-08-2012 |
Wonsuk Chang, Kenilworth, NJ US
Patent application number | Description | Published |
---|---|---|
20160068837 | SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES CONTAINING A 2' INTERNUCLEOSIDE LINKAGE - The present invention relates to RNAi molecules, and compositions thereof, comprising a 2′ internucleoside linkage connecting the nucleotide at position 1 and the nucleotide at position 2 at the 5′ end of the antisense strand. Specifically, the invention relates to single- and double-stranded short interfering nucleic acid (siNA) molecules that are capable of mediating RNA interference comprising 5′ modified nucleotides that comprise, among other potential modifications, a 2′ internucleoside linkage. The invention further relates to 5′ modified nucleotides used as reagents to generate the RNAi molecules of the invention and methods of using the disclosed RNAi molecules. | 03-10-2016 |
Wonsuk Chang, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20100279973 | SYNTHESIS OF PURINE NUCLEOSIDES - A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof. | 11-04-2010 |
20100286083 | NUCLEOSIDE ANALOGS - A purified compound having activity against hepatitis C virus is disclosed. | 11-11-2010 |
20110257121 | PURINE NUCLEOSIDE PHOSPHORAMIDATE - Disclosed herein is a compound represented by formula 1 or its hydrate thereof in crystalline or crystal-like form. | 10-20-2011 |
20120316327 | SYNTHESIS OF PURINE NUCLEOSIDES - A process for preparing phosphoramidate prodrugs or cyclic phosphate prodrugs of nucleoside derivatives, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof. | 12-13-2012 |
Yao-Jen Chang, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20140285486 | IMAGE-BASED 3D PANORAMA - Various disclosed embodiments include methods, systems, and computer-readable media for generating a 3-dimensional (3D) panorama. A method includes receiving images of a 3D scene. The method includes reconstructing geometry of a plurality of 3D bubble-views from the images. Reconstructing includes using a structure from motion framework for camera localization, generating a 3D surface mesh model of the scene using multi-view stereo via cylindrical surface sweeping for each bubble-view, and registering multiple 3D bubble-views in a common coordinate system. The method includes displaying the surface mesh model. | 09-25-2014 |
20150213646 | Method and System for Constructing Personalized Avatars Using a Parameterized Deformable Mesh - A method and apparatus for generating a 3D personalized mesh of a person from a depth camera image for medical imaging scan planning is disclosed. A depth camera image of a subject is converted to a 3D point cloud. A plurality of anatomical landmarks are detected in the 3D point cloud. A 3D avatar mesh is initialized by aligning a template mesh to the 3D point cloud based on the detected anatomical landmarks. A personalized 3D avatar mesh of the subject is generated by optimizing the 3D avatar mesh using a trained parametric deformable model (PDM). The optimization is subject to constraints that take into account clothing worn by the subject and the presence of a table on which the subject in lying. | 07-30-2015 |
Yuh-Jye Chang, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20120117563 | OVERLOAD CONTROL IN A CLOUD COMPUTING ENVIRONMENT - Provided is a method and devices for overload control in a cloud computing environment. The method includes receiving a first message from a network element associated with the cloud computing environment. The first message includes information associated with a target virtual machine and a list of sessions from the one or more sessions to move from the serving virtual machine to the target virtual machine. Associating one or more client addresses with an address associated with the target virtual machine based on the list of sessions. And, treating the target virtual machine as the serving virtual machine if processing sessions associated with the list of sessions. | 05-10-2012 |
20120324067 | METHOD AND APPARATUS FOR REMOTE DELIVERY OF MANAGED USB SERVICES VIA A MOBILE COMPUTING DEVICE - A managed Universal Serial Bus (USB) service capability is disclosed. The managed USB service capability is configured to use a mobile computing device (e.g., a smartphone or other suitable mobile computing device) to support a set of services for a computer (e.g., a desktop, a laptop, and the like) capable of connecting to the mobile computing device via a USB connection. The managed USB service capability enables local and/or remote control of the mobile computing device to operate in various USB device classes, such that the mobile computing device can provide various managed USB services for the computer via the peripheral connection. In this manner, the mobile computing device may be dynamically configured to operate as one or more of a network interface, a virtual private network (VPN) client, a smart card, a serial console, a mass-storage device, a booting device, and the like. | 12-20-2012 |
20130212275 | APPARATUS AND METHOD FOR MATCHING OFFERS AND REQUESTS FOR SHARING OF RESOURCES - A resource assignment capability is presented. A resource specification associated with a plurality of elements is received. The resource specification includes, for each of the elements, a resource request including an indication of a quantity of resources requested by the element and a resource offer including an indication of a quantity of resources offered by the element for use by one or more other elements. A resource assignment, including an indication of an association between the resources requests and the resource offers, is determined using a resource assignment process. The resource assignment process may be a greedy assignment process or a maximum flow resource assignment process. The maximum flow resource assignment process includes constructing a maximum flow resource graph based on the one or more resource specifications and applying a maximum flow process to the maximum flow resource graph to determine thereby the resource assignment. | 08-15-2013 |
Yu-Hwa Chang, West Windsor, NJ US
Patent application number | Description | Published |
---|---|---|
20090107881 | METHODS FOR INCREASING CATALYST CONCENTRATION IN HEAVY OIL AND/OR COAL RESID HYDROCRACKER - Methods and systems for hydrocracking a heavy oil feedstock using, a colloidally or molecularly dispersed catalyst (e.g., molybdenum sulfide) which provide for concentration of the colloidally dispersed catalyst within the lower quality materials requiring additional hydrocracking. In addition to increased catalyst concentration, the inventive systems and methods provide increased reactor throughput, increased reaction rate, and of course higher conversion of asphaltenes and lower quality materials. Increased conversion levels of asphaltenes and lower quality materials also reduces equipment fouling, enables the reactor to process a wider range of lower quality feedstocks, and can lead to more efficient use of a supported catalyst if used in combination with the colloidal or molecular catalyst. | 04-30-2009 |
20120009094 | SYSTEMS FOR INCREASING CATALYST CONCENTRATION IN HEAVY OIL AND/OR COAL RESID HYDROCRACKER - Systems for hydrocracking a heavy oil feedstock employ a colloidally or molecularly dispersed catalyst (e.g., molybdenum sulfide) which provide for concentration of the colloidally dispersed catalyst within the lower quality materials requiring additional hydrocracking. In addition to increased catalyst concentration, the inventive systems and methods provide increased reactor throughput, increased reaction rate, and of course higher conversion of asphaltenes and lower quality materials. Increased conversion levels of asphaltenes and lower quality materials also reduces equipment fouling, enables the reactor to process a wider range of lower quality feedstocks, and can lead to more efficient use of a supported catalyst if used in combination with the colloidal or molecular catalyst. | 01-12-2012 |
20130068658 | METHODS FOR INCREASING CATALYST CONCENTRATION IN HEAVY OIL AND/OR COAL RESID HYDROCRACKER - Methods for hydrocracking a heavy hydrocarbon feedstock (e.g., heavy oil and/or coal resid) employ a catalyst composed of well dispersed metal sulfide catalyst particles (e.g., colloidally or molecularly dispersed catalyst particles, such as molybdenum sulfide), which provide an increased concentration of metal sulfide catalyst particles within lower quality materials requiring additional hydrocracking. In addition to increased metal sulfide catalyst concentration, the systems and methods provide increased reactor throughput, increased reaction rate, and higher conversion of asphaltenes and lower quality materials. Increased conversion of asphaltenes and lower quality materials also reduces equipment fouling, enables processing of a wider range of lower quality feedstocks, and leads to more efficient use of a supported catalyst if used in combination with the well dispersed metal sulfide catalyst particles. | 03-21-2013 |
20130075304 | METHODS FOR INCREASING CATALYST CONCENTRATION IN HEAVY OIL AND/OR COAL RESID HYDROCRACKER - Methods and systems for hydrocracking a heavy oil feedstock include using a colloidal or molecular catalyst (e.g., molybdenum sulfide) and provide for concentration of the colloidal or molecular catalyst within the lower quality materials requiring additional hydrocracking in one or more downstream reactors. In addition to increased catalyst concentration, the inventive systems and methods provide increased reactor throughput, increased reaction rate, and of course higher conversion of asphaltenes and lower quality materials. Increased conversion levels of asphaltenes and lower quality materials also reduces equipment fouling, enables the reactor to process a wider range of lower quality feedstocks, and can lead to more efficient use of a supported catalyst if used in combination with the colloidal or molecular catalyst. | 03-28-2013 |